Neuroptis Dry Eye Project with ML 7 (Myosin Light Chain Inhibitor)

27 avril 2015

MAPK3/1 (ERK1/2) and Myosin Light Chain Kinase in Mammalian Eggs Affect Myosin-II Function and Regulate the Metaphase II State i

Biol Reprod. 2015 Apr 22. pii: biolreprod.114.127027. MAPK3/1 (ERK1/2) and Myosin Light Chain Kinase in Mammalian Eggs Affect Myosin-II Function and Regulate the Metaphase II State in a Calcium- and Zinc-Dependent Manner. McGinnis LA, Lee HJ, Robinson...

Posté par Eric Belot à 15:56 - Commentaires […] - Permalien [#]

Tags: ML7, Calcium, Cell Cycle, Cytoskeleton, MLCK, Meiotic spindle, Oocyte

Partager cet article

Vous aimez ?

1 vote

25 avril 2015

EVALUATION OF TOPICAL ADMINISTRATIONS OF ML7 IN A RAT MODEL OF SCOPOLAMINE-INDUCED DRY EYE. SIGNED REPORT.

Contract Research Organization: Ophthalmology Research - Iris Pharma Iris Pharma, a Contract Research Organization, provides preclinical and clinical research in ophthalmology: ocular safety, efficacy, ocular pharmacokinetics, clinical trials, bioanalytical...

Posté par Eric Belot à 13:33 - Commentaires […] - Permalien [#]

Tags: ML7, Dry eye, DED, 2014, Animals Efficacy, IRIS Pharma, Preservative-free, Statistics, Neuroptis Biotech, Precinical, Signed Study, Rats, Scopolamine

Partager cet article

Vous aimez ?

1 vote

24 avril 2015

BIOTECHFINANCES n°679 lundi 27 avril 2015

Biotech finances : Actualités Biotechs, Medtechs, Cap Risque : Biotech Finances BIOTECH FINANCES Editions Européennes de l'Innovation est un éditeur Européen qui diffuse une lettre d'information hebdomadaire des magazines et des produits spécialisés (cartographie)...

Posté par Eric Belot à 20:29 - Commentaires […] - Permalien [#]

Tags: Biotech Finances, Financing, Biomap, Biotechnology, Biovision

Partager cet article

Vous aimez ?

0 vote

23 avril 2015

LifeSciences News

Many Medicare patients undergo unnecessary routine preoperative tests before cataract surgery More than half of all Medicare patients who have cataract surgery undergo unnecessary routine preoperative testing, despite strong evidence that these tests...

Posté par Eric Belot à 19:09 - Commentaires […] - Permalien [#]

Tags: Neuroptis, Medical Device, Dry eye, DED, New Therapies, Cataract

Partager cet article

Vous aimez ?

0 vote

23 avril 2015

Eyenuk's EyeArt automated high-throughput diabetic retinopathy screening receives CE Mark

Eyenuk's EyeArt automated high-throughput diabetic retinopathy screening receives CE Mark Eyenuk Inc. Eyenuk Inc. Website http://www.eyenuk.com Eyenuk, Inc. announced today that it received CE Marking for its pioneering EyeArt software, a suite of advanced...

Posté par Eric Belot à 15:42 - Commentaires […] - Permalien [#]

Tags: Medical Device, Eye diseases, Diabetic Retinopathy

Partager cet article

Vous aimez ?

1 vote

23 avril 2015

Ophthalmology Innovation Summit @ASCRS, Is there an OIS effect ?

Adresse du Blog sur itunes: https://itunes.apple.com/us/podcast/ophthalmology-innovation-podcast/id904406267?mt=2%E2%80%8B Link, Corley, Chapin discuss funding innovation and private pay opportunities Craig Simak Managing Director at Healthegy and Producer...

Posté par Eric Belot à 13:36 - Commentaires […] - Permalien [#]

Tags: Medical Device, ophthalmology, Financing, Venture, Drug development, Innovation

Partager cet article

Vous aimez ?

1 vote

22 avril 2015

APOTCARE PRODUCTS AROUND THE EYE

Apotcare Boutique propulsée par PrestaShop http://apotcare.com

Posté par Eric Belot à 12:28 - Commentaires […] - Permalien [#]

Tags: Dry eye, DED, Cosmetic, Apotcare, Care, Wellness

Partager cet article

Vous aimez ?

1 vote

20 avril 2015

PUBLICATIONS UP TO APRIL 20th 2015

UPCOMING NEWS 1. Ocul Surf. 2015 Apr;13(2):118-132. doi: 10.1016/j.jtos.2014.12.001. Epub 2015 Jan 15. Clinical Guidelines for Management of Dry Eye Associated with Sjögren Disease. Foulks GN 1, Forstot SL 2, Donshik PC 3, Forstot JZ 4, Goldstein MH 5,...

Posté par Eric Belot à 17:32 - Commentaires […] - Permalien [#]

Tags: publications, Dry eye, 2015, ophthalmic news, update

Partager cet article

Vous aimez ?

0 vote

20 avril 2015

NEW THERAPEUTIC OPTIONS FOR DRY EYE

14. [Full body hydration and dry eye]. [Article in German] Messmer EM. Comment on Author response: is whole body hydration an important consideration in dry eye? [Invest Ophthalmol Vis Sci. 2013] Is whole-body hydration an important consideration in dry...

Posté par Eric Belot à 12:22 - Commentaires […] - Permalien [#]

Tags: publications, Dry eye, treatment, DED, 2014, Full body hydratation, Physiotherapy

Partager cet article

Vous aimez ?

0 vote

17 avril 2015

Amakem Therapeutics

AMAKEM THERAPEUTICS Amakem is a clinical stage ophthalmology company developing innovative new treatments for serious eye conditions. The Company’s lead program is based on AMA0076, a novel, locally-acting Rho kinase (ROCK) inhibitor, in clinical development...

Posté par Eric Belot à 20:24 - Commentaires […] - Permalien [#]

Tags: Biotech Finances, Dry eye, Rho Kinase Inhibitor, DED, Glaucoma, Amakem Therapeutics, Belgium, Venture

Partager cet article

Vous aimez ?

0 vote

17 avril 2015

Liens professionnels avec Twitter

Quelques liens Twitter concernant les sociétés/personnes de la famille: antoine le galloudec (@APOTCARE) | Twitter The latest Tweets from antoine le galloudec (@APOTCARE). Founder of APOT.CARE High end dermocosmetic skincare line. PARIS http://twitter.com...

Posté par Eric Belot à 20:05 - Commentaires […] - Permalien [#]

Tags: formulation, Neuroptis, Cosmetic, New Therapies, Apotcare, Belot

Partager cet article

Vous aimez ?

1 vote

15 avril 2015

Tear film osmolarity measurements using the TearLabTM ARVO 2014

245 Dry Eye Disease #1 Monday, May 05, 2014 11:00 AM–12:45 PM Exhibit/Poster Hall SA Poster Session Program #/Board # Range: 1967–2021/B0266–B0320 Organizing Section: Cornea Program Number: 1967 Poster Board Number: B0266 Presentation Time: 11:00 AM–12:45...

Posté par Eric Belot à 19:39 - Commentaires […] - Permalien [#]

Tags: Dry eye, diagnosis, DED, 2014, TEARLAB, ARVO, Veterinary

Partager cet article

Vous aimez ?

0 vote

14 avril 2015

Trial Runners

LINK: http://trialrunners.com Why Trial Runners? Trial Runners unique communication style involves working with clients every step of the way and removing typical communicational hierarchies in order to meet the demands of our clients. We believe that...

Posté par Eric Belot à 20:52 - Commentaires […] - Permalien [#]

Tags: Recruitment, Eye diseases, CRO, Clinica Trias, Runners, Sport

Partager cet article

Vous aimez ?

0 vote

13 avril 2015

Publications up to April 13 th 2015

PubMed Results Items 1 - 13 of 13 1. Cutan Ocul Toxicol. 2015 Apr 8:1-5. [Epub ahead of print] The ocular surface side effects of an anti-psychotic drug, clozapine. Ceylan E 1, Ozer MD, Yilmaz YC, Kartal B, Yildiz Ekinci D, Çinici E, Aksu Ceylan N. Author...

Posté par Eric Belot à 21:32 - Commentaires […] - Permalien [#]

Tags: publications, pictures, glands, Dry eye, diagnosis, DED, 2015, Scintigraphy

Partager cet article

Vous aimez ?

0 vote

11 avril 2015

Ocular Therapeutix

Link: http://www.ocutx.com OCULAR THERAPEUTIX EYE DRUG FAILS SECOND STUDY 7 Apr 2015 | PharmaBusiness Daily Ocular Therapeutix says its lead eye drug failed to meet one of the main goals in a second late-stage study, Reuters reports. The drug, OTX-DP,...

Posté par Eric Belot à 19:49 - Commentaires […] - Permalien [#]

Tags: treatment, Case Control study, New Therapies, Ocular Therapeutics, Plug

Partager cet article

Vous aimez ?

1 vote

9 avril 2015

U.S. FDA Grants Priority Review to Lifitegrast NDA for the Treatment of Dry Eye Disease in Adults

Shire has added a new press release to the Company's web site. To view the release, please click on the link below: http://www.shire.com/shireplc/en/investors/investorsnews/irshirenews?id=1089 See full text copy below: U.S. FDA Grants Priority Review...

Posté par Eric Belot à 21:41 - Commentaires […] - Permalien [#]

Tags: 2015, Shire, Lifitegrast, NDA

Partager cet article

Vous aimez ?

1 vote

9 avril 2015

Targeting Ocular Disorders Sept. Boston

Envisioning New Therapies Register Today | View Preliminary Agenda Ophthalmological pharmacology has historically lacked systematic understanding of disease mechanisms, especially of those for the back of the eye. This is now changing with the discovery...

Posté par Eric Belot à 20:07 - Commentaires […] - Permalien [#]

Tags: 2015, Boston, Eye diseases, Glaucoma, New Therapies, Research

Partager cet article

Vous aimez ?

1 vote

7 avril 2015

Herantis Pharma’s Phase 2 Dry Eye study recruitment completed ahead of schedule

Herantis Pharma’s Phase 2 Dry Eye study recruitment completed ahead of schedule Herantis Pharma’s Phase 2 Dry Eye study recruitment completed ahead of schedule Herantis Pharma Plc Company release 11 March 2015 at 10:00 am Dry Eye Herantis Pharma Plc has...

Posté par Eric Belot à 18:11 - Commentaires […] - Permalien [#]

Tags: Dry eye, treatment, Case Control study, DED, 2015, Phase 23, Herantis Pharma, Recruitment, cis-UCA

Partager cet article

Vous aimez ?

1 vote

6 avril 2015

New publications as April 6th, 2015

PUBLICATIONS UP TO APRIL 6TH 2015 1. Acta Ophthalmol. 2015 Apr 2. doi: 10.1111/aos.12710. [Epub ahead of print] Autologous serum and plasma rich in growth factors in ophthalmology: preclinical and clinical studies. Anitua E 1, Muruzabal F, Tayebba A,...

Posté par Eric Belot à 18:12 - Commentaires […] - Permalien [#]

Tags: publications, Dry eye, treatment, DED, 2015, Statistics

Partager cet article

Vous aimez ?

1 vote

3 avril 2015

TEARLAB DEVICE

Link: http://www.tearlab.com Product Information What is TearLab? Manage Your Dry Eye Patients with Confidence The TearLab Osmolarity System is the first objective and quantitative test for diagnosing and managing Dry Eye patients. Fast and accurate results...

Posté par Eric Belot à 13:55 - Commentaires […] - Permalien [#]

Tags: Medical Device, Dry eye, diagnosis, DED, Ocular Technologies, Osmolarity, TEARLAB

Partager cet article

Vous aimez ?

1 vote